Welcome to our dedicated page for Genworth Finl SEC filings (Ticker: GNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Genworth Financial, Inc. (NYSE: GNW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports, annual reports, and quarterly reports filed with the U.S. Securities and Exchange Commission. As a publicly traded holding company with operations in long-term care insurance, life and annuities, and U.S. mortgage insurance through Enact Holdings, Inc. (Nasdaq: ACT), Genworth uses these filings to present detailed financial and segment information.
Investors reviewing GNW SEC filings can examine how Genworth reports results for its Enact, Long-Term Care Insurance, and Life and Annuities segments, along with holding company activities. Filings such as Form 10-K and Form 10-Q typically include discussions of net income, adjusted operating income, segment performance, investment results, statutory capital measures, and risk-based capital ratios for U.S. life insurance subsidiaries. They also describe Genworth’s use of non-GAAP measures, including how adjusted operating income is defined and reconciled to GAAP net income.
Current reports on Form 8-K, such as the filing dated November 5, 2025, document material events including the release of quarterly financial results and the availability of related press releases and financial supplements. These filings often reference exhibits that contain detailed data tables and segment disclosures.
Through Stock Titan, users can follow GNW filings in real time as they are posted to the SEC’s EDGAR system. AI-powered tools summarize lengthy documents, highlight key themes such as capital allocation, share repurchase authorizations, segment trends, and legal or regulatory updates, and help clarify the implications of complex items like liability remeasurement in long-term care, reserve releases in mortgage insurance, or changes in market risk benefits. The filings page can also surface insider transaction reports on Form 4 and proxy-related disclosures when available, giving a fuller view of executive and governance-related information.
Genworth Financial Inc ownership filing reports that The Vanguard Group beneficially owns 0 shares of Common Stock, representing 0% of the class. The filing states Vanguard completed an internal realignment on January 12, 2026 and certain subsidiaries now report separately in reliance on SEC Release No. 34-39538.
The statement explains those subsidiaries pursue the same investment strategies and that Vanguard no longer is deemed to beneficially own securities held by those entities.
Genworth Financial, Inc. shareholder Scott Klarquist submitted an open letter and four shareholder proposals seeking (1) a special committee to consider strategic alternatives for Genworth's stake in Enact Holdings, (2) proxy access, (3) enhanced CEO succession planning disclosure and (4) an in-person annual meeting option.
Klarquist cites an Enact stake of 115,223,783 shares as of December 31, 2025 and notes a cited enterprise value comparison of $3.7 billion versus Enact market value just over $4.6 billion, arguing this gap implies a per-share arithmetic value near $10.46 versus Genworth's recent stock price around $8.16.
Genworth Financial is soliciting proxies for its 2026 Annual Meeting to be held virtually on May 20, 2026 and asks stockholders to vote on election of ten directors, advisory approval of executive compensation, a new Associate Stock Purchase Plan, and ratification of KPMG as auditor.
The letter highlights 2025 progress: $245 million of share repurchases at an average price of $7.99, a new $350 million repurchase authorization, $558 million of adjusted operating income at Enact, Genworth's Enact-related book value of $4.4 billion at year-end 2025, and receipt of $407 million of Enact capital returns. The company emphasizes CareScout growth, the acquisition of Seniorly, a pilot to enhance long-term care claims experience, and creation of a permanent Technology Committee.
Woodell Darren W. reported acquisition or exercise transactions in this Form 4 filing.
Genworth Financial reported that VP and Controller Darren W. Woodell received a grant of 18,743 cash-settled restricted stock units. The award is recorded at a price of $0.00 per unit, reflecting compensation rather than an open-market purchase.
According to the terms, each unit represents a contingent right to receive a cash payment equal to the value of one share of Genworth common stock on each of March 2, 2027, March 2, 2028 and March 2, 2029. After this grant, Woodell holds 18,743 such units directly.
Genworth Financial President and CEO Thomas J. McInerney exercised 665,574 Performance Stock Units that fully vested on March 2, 2026, receiving common shares on a 1:1 basis. To cover related tax obligations, the company withheld 304,135 shares at $8.46 per share. After these transactions, he held 5,468,883 shares directly and 89,456 shares indirectly through trusts for children.
Genworth Financial EVP & CFO Jerome T. Upton reported equity compensation and related share movements in company stock. He received a grant of 91,429 Restricted Stock Units at no cost, which settle into Common Stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027.
On March 2, 2026, Performance Stock Units granted on February 16, 2023 fully vested and were settled in Common Stock on a 1:1 basis, adding 83,196 shares of Common Stock. To cover tax withholding on the vested Performance Stock Units, the company withheld 36,555 shares of Common Stock at $8.46 per share. After these transactions, Upton directly held 560,388 shares of Common Stock and 91,429 Restricted Stock Units.
Genworth Financial executive Taylor C. Morris, EVP & CIO, received a grant of 45,714 Restricted Stock Units on March 2, 2026. These RSUs settle into common stock on a 1:1 basis. They are scheduled to vest and convert to common shares in three equal installments beginning on March 2, 2027.
Genworth Financial executive Samir B. Shah, President & CEO of CareScout Services, reported several equity compensation moves. He received a grant of 102,857 Restricted Stock Units, which settle into common stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027. Separately, Performance Stock Units granted on February 16, 2023 fully vested on March 2, 2026 and were settled into 36,381 shares of common stock. To cover tax withholding for the vested performance units, 18,595 shares of common stock were withheld at a price of $8.46 per share, leaving Shah with 115,954 common shares held directly after these transactions.
Genworth Financial executive Kelly A. Saltzgaber reported equity compensation and related share movements. On March 2, 2026, Saltzgaber received a grant of 68,571 Restricted Stock Units, which settle into common stock on a 1:1 basis and vest in three equal installments beginning on March 2, 2027.
On the same date, Performance Stock Units granted on February 16, 2023 fully vested and were settled into 49,918 shares of common stock. To cover tax withholding on the vested Performance Stock Units, the company withheld 23,133 shares at a price of $8.46 per share. Following these transactions, Saltzgaber directly owned 135,848 shares of common stock and 68,571 Restricted Stock Units.